Filing Details

Accession Number:
0001683168-22-000103
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-01-05 19:54:18
Reporting Period:
2022-01-03
Accepted Time:
2022-01-05 19:54:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
704562 Avid Bioservices Inc. CDMO Pharmaceutical Preparations (2834) 953698422
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1346342 R Daniel Hart 2642 Michelle Drive, Suite 200
Tustin CA 92780
Chief Financial Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Acquisiton 2022-01-03 500 $5.66 27,833 No 4 M Direct
Common Stock, $0.001 Par Value Disposition 2022-01-03 500 $29.07 27,333 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2022-01-03 500 $0.00 500 $5.66
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
232,380 2028-08-01 No 4 M Direct
Footnotes
  1. The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 15, 2021.
  2. Stock option granted to the reporting person on August 1, 2018, vests in four (4) equal annual installments beginning August 1, 2019 and each year thereafter until fully-vested, subject to the reporting person's continuous service to the Issuer on such vesting dates.